Works matching IS 03407004 AND DT 2008 AND VI 57 AND IP 10
Results: 15
Induction of immune response against NY-ESO-1 by CHP-NY-ESO-1 vaccination and immune regulation in a melanoma patient.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 10, p. 1429, doi. 10.1007/s00262-008-0478-5
- By:
- Publication type:
- Article
Gamma-IFN-inducible-lysosomal thiol reductase modulates acidic proteases and HLA class II antigen processing in melanoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 10, p. 1461, doi. 10.1007/s00262-008-0483-8
- By:
- Publication type:
- Article
Whole-cell cancer vaccination: from autologous to allogeneic tumor- and dendritic cell-based vaccines.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 10, p. 1569, doi. 10.1007/s00262-008-0536-z
- By:
- Publication type:
- Article
Generation of antigen-specific CTL responses using RGS1 mRNA transfected dendritic cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 10, p. 1483, doi. 10.1007/s00262-008-0486-5
- By:
- Publication type:
- Article
Spontaneous immune responses to sporadic tumors: tumor-promoting, tumor-protective or both?
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 10, p. 1531, doi. 10.1007/s00262-008-0501-x
- By:
- Publication type:
- Article
Translating immunity into cancer therapy: new findings from the first conference of the European Society for Cancer Immunology and Immunotherapy, an ESMO-EIS held in Athens, 15–17 November 2007.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 10, p. 1505, doi. 10.1007/s00262-008-0484-7
- By:
- Publication type:
- Article
NK cell-mediated targeting of human cancer and possibilities for new means of immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 10, p. 1541, doi. 10.1007/s00262-008-0492-7
- By:
- Publication type:
- Article
Lung cancer patients’ CD4<sup>+</sup> T cells are activated in vitro by MHC II cell-based vaccines despite the presence of myeloid-derived suppressor cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 10, p. 1493, doi. 10.1007/s00262-008-0490-9
- By:
- Publication type:
- Article
Immune, endocrine, and behavioral precursors to breast cancer recurrence: a case-control analysis.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 10, p. 1471, doi. 10.1007/s00262-008-0485-6
- By:
- Publication type:
- Article
IL-21 induces in vivo immune activation of NK cells and CD8<sup>+</sup> T cells in patients with metastatic melanoma and renal cell carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 10, p. 1439, doi. 10.1007/s00262-008-0479-4
- By:
- Publication type:
- Article
Zoledronic acid modulates antitumoral responses of prostate cancer-tumor associated macrophages.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 10, p. 1451, doi. 10.1007/s00262-008-0482-9
- By:
- Publication type:
- Article
The E75 HER2/ neu peptide vaccine.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 10, p. 1511, doi. 10.1007/s00262-008-0540-3
- By:
- Publication type:
- Article
Dendritic cell vaccination and immune monitoring.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 10, p. 1559, doi. 10.1007/s00262-008-0553-y
- By:
- Publication type:
- Article
Anti-angiogenesis: making the tumor vulnerable to the immune system.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 10, p. 1553, doi. 10.1007/s00262-008-0524-3
- By:
- Publication type:
- Article
Combined modality immunotherapy and chemotherapy: a new perspective.
- Published in:
- Cancer Immunology, Immunotherapy, 2008, v. 57, n. 10, p. 1523, doi. 10.1007/s00262-008-0531-4
- By:
- Publication type:
- Article